Myriad Genetics

tumor BRACAnalysis CDx™

Biomarkers / Diagnostic
Cancer
Companion diagnostic tumor testing for mutations in BRCA1/2 genes indicated for patients with ovarian cancer treated with IPARP
4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
España